The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[18F]-5-6-Benzyl-N-(2-fluoroethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide ID: ALA1210368
PubChem CID: 25210565
Max Phase: Preclinical
Molecular Formula: C19H17FN2O2
Molecular Weight: 324.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCC[18F])c1c[nH]c2ccc(Cc3ccccc3)cc2c1=O
Standard InChI: InChI=1S/C19H17FN2O2/c20-8-9-21-19(24)16-12-22-17-7-6-14(11-15(17)18(16)23)10-13-4-2-1-3-5-13/h1-7,11-12H,8-10H2,(H,21,24)(H,22,23)/i20-1
Standard InChI Key: FQCVKMJBEWJMHR-LRFGSCOBSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-3.3098 0.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3109 -0.0482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5961 -0.4610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8797 -0.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8825 0.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5979 1.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1696 1.1980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4536 0.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4538 -0.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2613 -0.4442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2537 1.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9695 0.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9750 -0.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6922 -0.4369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4084 -0.0196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4029 0.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6811 1.2222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6745 2.0471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1150 1.2264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8318 0.8180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1104 2.0514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8365 -0.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5533 -0.4155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5579 -1.2405 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11 8 1 0
12 13 1 0
5 6 2 0
6 1 1 0
1 2 2 0
5 7 1 0
3 4 2 0
7 8 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
8 9 2 0
16 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
19 21 2 0
10 13 2 0
20 22 1 0
2 3 1 0
22 23 1 0
12 11 2 0
23 24 1 0
M ISO 1 24 18
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.36Molecular Weight (Monoisotopic): 324.1274AlogP: 2.82#Rotatable Bonds: 5Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.11CX Basic pKa: ┄CX LogP: 3.25CX LogD: 3.25Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -0.71
References 1. Gaeta A, Woodcraft J, Plant S, Goggi J, Jones P, Battle M, Trigg W, Luthra SK, Glaser M.. (2010) Use of 2-[(18)F]fluoroethylazide for the Staudinger ligation - Preparation and characterisation of GABA(A) receptor binding 4-quinolones., 20 (15): [PMID:20579877 ] [10.1016/j.bmcl.2010.05.106 ]